Melanin is a heterogeneous biopolymer which is principally responsible for human phenotypic appearance and has major role in protecting human skin from harmful effect of UV-radiation from the sun.
It is also reported to be linked to Parkinson diseases and some other neurodegerative diseases. 8, 9) Therefore, the regulation of melanin synthesis by inhibiting the tyrosinase enzyme is the current research topic in context of preventing hyperpigmentation. In this regard, diverse tyrosinase inhibitors have been actively discovered such as kojic acid, 10, 11) arbutin, 12) ascorbic acid derivatives, 13) hydroxylstilbine derivatives like resveratol [14] [15] [16] and methyl ester of genistic acid. 17, 18) However, according to a recent study kojic acid has serious adverse effects such as skin cancer and dermatitis and has been banned as a cosmetic ingredient in many countries. 17) Thus other type of molecules, which inhibit cyclic adenosine monophosphate (cAMP) dependent melanogenesis proteins other than tyrosinase, are gaining attention. Using bioassay system for measuring the amount of melanin formed from melanoma B16 cells upon stimulation of a-melanocyte stimulating hormone (a-MSH), we have screened many different compounds. As a result, 6-methyl-3-phenethyl-3,4-dihydro-1H-quinoline-2-thione ( Fig.  1 , IC 50 ϭ0.8 mM) was discovered as highly potent compound against melanogenesis in melanoma B16 cell line.
18) The mechanism of action of compound 1 is very much unique and important due to its suppression of the melanogenesis without affecting the tyrosinase activity. The preliminary study on the structure-activity relationship (SAR) of 1 has revealed quinazolidine-2-thione in 1 as an essential motif. 18) In order to explore the necessity of 6-membered cyclic thiourea scaffold in 1, benzo[d]imidazol-2(3H)-ones 4 ( Fig.  1) containing 5-membered cyclic thiourea were designed, synthesized and evaluated for their inhibitory activity against melanin production in melanoma B16 cells under the stimulation of a-MSH.
Chemistry
Benzo[d]imidazol-2(3H)-ones 4 and benzo[d]imidazole-2(3H)-thiones 5 were synthesized with the synthetic procedure as shown in Chart 1. In the first step, commercially available amine 6 was treated with appropriate alkyl bromide using pyridine or sodium hydroxide to give an intermediate 7. 18, 19) In case of benzylated amines 7, the reduction reaction was carried out with iron powder in acetic acid at 50-70°C temperature for 2 h to yield 8. 20) To get the another important intermediate 10, the phenyl chloroformate was reacted with 7 under refluxing condition for 7 h to achieve 9, 21) which was subsequently subjected to reduction using catalytic hydrogenation at ambient temperature to produce 10. 22) Further the diamine 8 was treated with phenyl chloroformate using xylene at refluxing temperature for 33 h to give title compound 4. 21) On the other hand, 10 in xylene underwent cyclization at reflux temperature to produce 4. 21) Finally, benzo[d]imidazol-2(3H)-ones 4 in toluene treated with Lawesson's reagent at reflux temperature to obtain the corresponding thiones 5.
23)

Results and Discussion
For all the synthesized compounds 4 and 5 the ability to inhibit formation of melanin from melanoma B-16 cells was determined under stimulus of a-MSH (100 nM) for 3 d incubation. Melanoma B16 cell (CRL6323) were obtained from ATCC (Manassas, U.S.A.). Amounts of melanin released into the culture media were determined by measuring absorbance values at 405 nm with synthetic melanin as the standard. 24) Data for % inhibition at 10 mM and IC 50 values are mean values from 3 to 5 separate experiments as shown in Table 1 .
Among the synthesized compounds the benzimidazole-2(3H)-thiones 5 shows promising inhibitory activity against melanin production in melanoma B16 cells as compared to kojic acid (IC 50 ϭ70 mM) and arbutin (IC 50 ϭ180 mM). Interestingly, these compounds 5 have almost comparable activity to 1 (Ͼ100% inhibition at 10 mM, IC 50 ϭ0.8 mM). The potent compound 5c (Ͼ100% inhibition at 10 mM, IC 50 ϭ1.5 mM) has almost similar structure to that of 1 with an exception of one methylene unit on heterocyclic motif. This result intimates that the activities of both quinazolidine-2-thione 1 and benzimidazolidine-2-thione 5 are not dependent on variation of ring size. In our previous studies 24) we observed that imidazolidine-2-thione analog 2 (42% inhibition at 10 mM, IC 50 ϭ Ͼ10 mM) exhibited very low activity unlike six membered cyclic thiourea 3 (93% inhibition at 10 mM, IC 50 ϭ2.9 mM) as shown in Fig. 1 . Thus, the benzene ring fused with imidazolidine-2-thione of 5 is an essential motif for their inhibitory activity. Moreover, different position of phenylalkyl substituent on cyclic thiourea unit in 1 and 5 does not affect the activity.
Methyl and chloro substituents at position 5 of benzimidazole-2-thione of 5 do not change activity as shown in the activity of 5a (Ͼ100% inhibition at 10 mM, IC 50 ϭ1.7 mM, C log Pϭ3.521) and 5b (Ͼ100% inhibition at 10 mM, IC 50 ϭ 1.9 mM, C log Pϭ3.735). Likewise, compound 5c (Ͼ100% inhibition at 10 mM, IC 50 ϭ1.5 mM, C log Pϭ3.850), 5d (Ͼ 100% inhibition at 10 mM, IC 50 ϭ1.3 mM, C log Pϭ4.229) and 5e (Ͼ100% inhibition at 10 mM, IC 50 ϭ2.0 mM, C log Pϭ 4.064) show similar level of activity. This indicates that the size of side chain and the lipophilicity of compounds 5 do not have much influence on their inhibitory activity.
Unlike benzimidazole-2(3H)-thiones 5, their counterpart benzo[d]imidazol-2(3H)-ones 4a-e gave a very weak inhibitory activity (their IC 50 values were more than 10 mM and inhibition was less than 30% at 10 mM). Thus thiourea unit of 5 is very critical for the activity, which was also observed in our previous studies with analogs of 1.
25)
Conclusion
Taken our studies together, the benzimidazole-2(3H)-thione motif of 5 is an essential structural unit for their inhibitory activity. Among all thiones (5a-e), the compound 5d (IC 50 ϭ1.3 mM) most strongly inhibits the melanin formation. Therefore benzo[d]imidazole-2(3H)-thiones 5 could be quite promising compound for the treatment of hyperpigmentation.
Experimental
General Procedures Melting points (mp) were determined on Electro thermal 1A 9100 MK2 apparatus and are uncorrected. All commercial chemicals were used as obtained and all solvents were purified by the standard procedures prior to use. Thin layer chromatography was performed on E Merck silica gel GF-254 per-coated plates and the identification was done with UV light and colorization with spray 10% phosphomolybdic acid followed by heating. Flash column chromatography was performed with E Merck silica gel (230-400 mesh). IR spectra were recorded with Jasco IR-Report-100 IR spectrometer in cm Ϫ1 and corrected against peak at 1601 cm Ϫ1 of polystyrene. NMR spectra were measured against the peak of tetramethylsilane by Varian Unity Inova 400 NMR (400 MHz) spectrometers. High resolution-mass spectrum (HR-MS) was recorded on API2000 mass spectrometer (PE Sciex, Toronto, Canada).
Synthesis of N-Benzyl-4-methyl-2-nitrobenzenamine (7a) 4-Methyl-2-nitroaniline (6a, 3 g, 19.0 mmol) and pyridine (4.78 ml, 59.0 mmol) were dissolved in methylenechloride (150 ml). After stirred for 10 min, benzyl bromide (3.52 ml, 29.0 mmol) was added. The resulting reaction mixture was refluxed for 16 h. After cooled, the reaction mixture was washed with water three times. The organic layer was dehydrated with anhydrous sodium sulfate and solvent was removed under vacuum. The desired compound 7a was isolated by column chromatography. a) The activity associated with compound 1 was reported in ref. 18 . b) The activity associated with compounds 2 and 3 was reported in ref. 24 . c) C log P values were calculated by Chemdraw ver. 9.0. Synthesis of Phenyl N-(4-Methyl-2-aminophenyl)-N-phenylethylcarbamate (10a) Compound 9a (1.5 g, 3.0 mol) was dissolved in the co-solvent (30 ml) of ethanol and dichloromethane (1 : 2). After addition of Pd-C (0.150 g), the mixture was stirred under hydrogen gas (45 psi) for 12 h at room temperature. After filtration through celite pad, the filtrate was evaporated under vacuum to give pure 10a. 
Synthesis of 1-Benzyl-5-methyl-1H-benzo[d]imidazol-2(3H)-one (4a)
To the solution of diamine 8a (0.500 g, 2.0 mmol) in xylene (10 ml), phenylchloroformate (0.325 ml, 2.2 mmol) was added in drop wise. The resulting mixture was refluxed for 33 h. After cooling, xylene was removed under vacuum. The residue was dissolved in dichloromethane (100 ml) and extracted with water (70 ml) twice. The organic layer was dehydrated over anhydrous sodiumsulfate and evaporated under vacuum. The residue was subjected to column chromatography for isolation of 4a. 
Synthesis of 5-Methyl-1-phenethyl-1H-benzo[d]imidazol-2(3H)-one (4c)
To the solution of compound 10a (0.500 g, 1.4 mmol) in toluene (20 ml), sodium hydroxide (0.115 g, 2.8 mmol) and water (0.5 ml) were added. The resulting mixture was refluxed for 3 h. After cooled, toluene was removed under vacuum. The residue was dissolved in dichloromethane (100 ml) and extracted with water (70 ml) twice. The organic layer was dehydrated with anhydrous sodiumsulfate and evaporated under vacuum. The residue was subjected to column chromatography for isolation of 10c. 
